Antibody-Extractor accelerates COVID-19 research

AbnomX is pleased to welcome the University of Lisbon as a new user of Antibody-Extractor.

Dr. João Gonçalves  from the Faculdade de Farmácia is planning to use the new version of the software platform for his COVID-19 research. The scientists at the University of Lisbon intend to analyze the B-cell repertoire of COVID-19 patients with Antibody-Extractor and will rely on AbnomX for T-cell repertoire analysis with proprietary research tools.